allergan.ca


allergan.ca Website Info

allergan.ca (AbbVie | Pharmaceutical Research & Development) was registered first at 2000-11-01 21:18:24. DNS looks Active and website looks Accessable. allergan.ca Website SEMRush Rank is 2,124,106. According to Google, website speed score is 0/100 and . Website looks safe for children. We detected the website language as en.
allergan.ca


allergan.ca Website Tags

Domain Status:
✓ Active
Is Site Accessable?:
✓ Yes
SSL(https):
✓ Yes
Title:
AbbVie | Pharmaceutical Research & Development
Description:
AbbVie | Pharmaceutical Research & Development
Categories :
Business, Health and Wellness
External Links:
9
Internal Links:
53
Canonical URL:
[Not Set]
Language:
en
XML Sitemap:
✗ No
robots.txt:
✗ No
Favicon:
✓ Yes

allergan.ca Domain & Whois Details

Refresh
Domain Create Date:
2000-11-01 21:18:24
Domain Age:
24 years, 8 months, 1 days
Domain Expire Date:
2024-06-01T04:00:00Z
Domain Last Update Date:
2024-06-01T04:00:00Z
Domain Owner:
Markmonitor.com - MarkMonitor International Canada Ltd. - Registrant AbbVie Corporation - Admin Nicolas Michaud - Tech Nicolas Michaud - Billing CCOPS Billing -
Server Software:
ASP.NET
Server Type:
cloudflare
Nameservers:
ns11.constellix.com - ns21.constellix.com - ns31.constellix.com - ns41.constellix.net - ns51.constellix.net - ns61.constellix.net -
Hosting Location:
Country:United States, City:Lake Bluff, Isp:AbbVie, Inc., Org:
IP:
159.180.132.181

allergan.ca Backlinks & Rankings

SEMRush Rank:
2,124,106
Semrush Rank is a proprietary score that lets you find the domains that are getting the most traffic from organic search.
SEMRush Traffic:
301
Number of users expected to visit the website during the following month.
SEMRush Costs:
349
Estimated price of organic keywords in Google AdWords.
SEMRush URL Links:
52
Number of links to URL according to SemRush.
SEMRush Website Links:
187
Number of links to the website according to SemRush.
SEMRush Domain Links:
20,766
Number of links to SemRush Domain.
SEMRush Keywords In Top 100:
532
Number of keywords where site in Google's organic search top 100.

allergan.ca Social Media

Facebook Comments:
0
Facebook Shares:
1
Facebook Reactions:
0

allergan.ca Website Speed (Desktop) Check Now

Speed analysis has not been completed yet. Our system will be checking this website soon.


allergan.ca Website Safety

Refresh
Last Check Date:
6/25/2023 2:32:07 PM
Fortiguard:
Health and Wellness
Mcafee Category:
Business
OpenDNS:
BeFirst
Cloudflare DNS:
OK
MyWot Child Safety:
99

allergan.ca HTTP Headers

Refresh
Cache-Control :
private, no-store, must-revalidate
Content-Type :
text/html; charset=utf-8
Date :
Mon, 05 Jun 2023 06:40:00 GMT
request-context :
appId=cid-v1:05dcb622-6368-4b1f-9f44-86ef7d964c9c
Server :
Microsoft-IIS/10.0
Set-Cookie :
CMSPreferredCulture=en-CA; expires=Wed, 05-Jun-2024 06:39:59 GMT; path=/; HttpOnly,ASP.NET_SessionId
Transfer-Encoding :
chunked
X-AspNet-Version :
4.0.30319
X-Frame-Options :
SAMEORIGIN
X-Powered-By :
ASP.NET
X-UA-Compatible :
IE=Edge


allergan.ca W3C HTML Validation Check Now

Last Check Date:
6/3/2023 12:00:00 AM
Errors:
14
Warnings:
0
Info:
11

allergan.ca Similar Sites

Website
Title
Rank
Allergan Aesthetics UK | An AbbVie Company
3,546,853
AbbVie | Pharmaceutical Research & Development
Pharmaceutical Research & Development | AbbVie
16,841
AbbVie Canada | Innovation in Healthcare and Biotechnology
1,214,250

allergan.ca Site Keywords

Allergan
Biosimilar
brand
development
Pharmaceutical
pharmaceutical company
Pharmaceutical Research
specialty

allergan.ca Site H Tags

Check Now
h1
Great People. Great Products. Greater Opportunity.
h3
Select your country
h6
Global
h6
Africa
h6
Americas
h6
Asia Pacific
h6
Europe

allergan.ca Sites with Same Names

Website
Title
Rank
Allergan Colombia - compañía farmacéutica - Allergan
9,488,152
Allergan Aesthetics Argentina | An AbbVie Company
8,323,364
Allergan Aesthetics Latin America | An AbbVie Company
7,268,401
AestheticsRebrand
6,420,613
AestheticsRebrand
5,997,722
AestheticsRebrand
5,474,840
Allergan Aesthetics | An AbbVie Company
5,268,134
allergan new zealand - leading growth pharma - allergan
4,539,865
AestheticsRebrand
4,212,004
Allergan Aesthetics UK | An AbbVie Company
3,546,853
India - Leading Growth Pharma - Allergan
2,841,266
Allergan: Leading Innovator in Medical Aesthetics and Healthcare
22,689
AbbVie | Farmaceutický výzkum & rozvoj
18,746,880
Aesthetics
18,431,923
AestheticsRebrand
14,719,872
Portugal - companhia farmacêutica - Allergan
11,550,978
Allergan Chile - Leading Growth Pharma - Allergan
10,218,784
Allergan - Leading Growth Pharma - Allergan
allergan | AbbVie
アラガン・ジャパン株式会社(Allergan Japan)
Allergan Aesthetics Netherlands | An AbbVie Company
Allergan Aesthetics Spain | An AbbVie Company
AestheticsRebrand
AbbVie | Pharmaceutical Research & Development

What is SitesDB?

SitesDB is one of the largest databases of websites and domain names on the internet, with over 40 million entries and growing. For more than 12 years, we've been manually verifying and updating website and domain details, combining human expertise with AI-powered systems to ensure the accuracy and relevance of our data.

At SitesDB, we provide in-depth technical and useful information about websites and domains, including:

  • Website meta tags
  • Domain & WHOIS data
  • General backlink and ranking statistics
  • Social media engagement stats
  • Root page speed insights
  • Website content and HTML resources
  • Website safety and security details, sourced from multiple trusted security providers
  • HTTP headers analysis
  • HTML validation reports
  • Lists of similar websites and competitors
  • Website keyword analysis, including top traffic-driving keywords
  • Heading structure (H tags) breakdown
  • Domain variations across different TLDs (Top-Level Domains)

In addition to this data, SitesDB offers a suite of website analysis tools — including Chrome CRUX, Google Lighthouse, and our own AI-enhanced algorithms — to help identify alternative websites, direct competitors, and similar sites, all continuously refined through both automated systems and human review.